These injections aren't completely without risks Recently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the stigma around such treatments
Novo Nordisk, a competitor to Eli Lilly, has already sought FDA approval for an oral semaglutide pill, its oral GLP-1 pill, and is expected to receive a decision by the end of this year
They provide a much stronger and longer-lasting signal than your bodys natural GLP-1 can produce on its own
Safety: What risk of adverse effects, if any, do Pendulums products pose
Popular branded versions include: Ozempic (semaglutide) : Approved for Type 2 diabetes Wegovy (semaglutide) : Approved for chronic weight management Mounjaro (tirzepatide) : Newer dual-action drug also making waves GLP-1 drugs are typically injected weekly and have been shown to reduce blood sugar levels and body weight dramatically
Aronne noted